Literature DB >> 25056656

Osteopontin: a new player in regulating hepatic ductular reaction and hepatic progenitor cell responses during chronic liver injury.

Mario Strazzabosco1, Luca Fabris2, Emanuele Albano3.   

Abstract

Entities:  

Keywords:  BILIARY EPITHELIUM; CHRONIC LIVER DISEASE; LIVER REGENERATION

Mesh:

Substances:

Year:  2014        PMID: 25056656      PMCID: PMC4519840          DOI: 10.1136/gutjnl-2014-307712

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  11 in total

1.  Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling.

Authors:  Raquel Urtasun; Aritz Lopategi; Joseph George; Tung-Ming Leung; Yongke Lu; Xiaodong Wang; Xiaodong Ge; Maria Isabel Fiel; Natalia Nieto
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

Review 2.  Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases.

Authors:  Toshimitsu Uede
Journal:  Pathol Int       Date:  2011-03-08       Impact factor: 2.534

Review 3.  Emerging roles of Notch signaling in liver disease.

Authors:  Fabian Geisler; Mario Strazzabosco
Journal:  Hepatology       Date:  2014-09-19       Impact factor: 17.425

4.  Osteopontin: Versatile modulator of liver diseases.

Authors:  Sumiko Nagoshi
Journal:  Hepatol Res       Date:  2013-06-20       Impact factor: 4.288

5.  Osteopontin induces ductular reaction contributing to liver fibrosis.

Authors:  Xiaodong Wang; Aritz Lopategi; Xiaodong Ge; Yongke Lu; Naoto Kitamura; Raquel Urtasun; Tung-Ming Leung; Maria Isabel Fiel; Natalia Nieto
Journal:  Gut       Date:  2014-02-04       Impact factor: 23.059

Review 6.  Epithelial-mesenchymal interactions in biliary diseases.

Authors:  Luca Fabris; Mario Strazzabosco
Journal:  Semin Liver Dis       Date:  2011-02-22       Impact factor: 6.115

Review 7.  Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion.

Authors:  Michael J Williams; Andrew D Clouston; Stuart J Forbes
Journal:  Gastroenterology       Date:  2013-12-04       Impact factor: 22.682

8.  Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice.

Authors:  J D Coombes; M Swiderska-Syn; L Dollé; D Reid; B Eksteen; L Claridge; M A Briones-Orta; S Shetty; Y H Oo; A Riva; S Chokshi; S Papa; Z Mi; P C Kuo; R Williams; A Canbay; D H Adams; A M Diehl; L A van Grunsven; S S Choi; W K Syn
Journal:  Gut       Date:  2014-06-05       Impact factor: 23.059

9.  Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice.

Authors:  Romina Fiorotto; Aileen Raizner; Carola M Morell; Barbara Torsello; Roberto Scirpo; Luca Fabris; Carlo Spirli; Mario Strazzabosco
Journal:  J Hepatol       Date:  2013-03-07       Impact factor: 25.083

10.  Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans.

Authors:  James Pritchett; Emma Harvey; Varinder Athwal; Andrew Berry; Cliff Rowe; Fiona Oakley; Anna Moles; Derek A Mann; Nicoletta Bobola; Andrew D Sharrocks; Brian J Thomson; Abed M Zaitoun; William L Irving; Indra N Guha; Neil A Hanley; Karen Piper Hanley
Journal:  Hepatology       Date:  2012-09       Impact factor: 17.425

View more
  10 in total

1.  Serum osteopontin is a predictor of prognosis for HBV-associated acute-on-chronic liver failure.

Authors:  Longgen Liu; Jianchun Lu; Chunyan Ye; Lin Lin; Shuqin Zheng; Hongyu Zhang; Qing Lan; Yuan Xue
Journal:  Biomed Rep       Date:  2017-12-13

Review 2.  Reversibility and heritability of liver fibrosis: Implications for research and therapy.

Authors:  Hussein M Atta
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

3.  Genetic lineage tracing analysis of the cell of origin of hepatotoxin-induced liver tumors in mice.

Authors:  Soona Shin; Kirk J Wangensteen; Monica Teta-Bissett; Yue J Wang; Elham Mosleh-Shirazi; Elizabeth L Buza; Linda E Greenbaum; Klaus H Kaestner
Journal:  Hepatology       Date:  2016-05-28       Impact factor: 17.425

4.  Interleukin 2 Promotes Hepatic Regulatory T Cell Responses and Protects From Biliary Fibrosis in Murine Sclerosing Cholangitis.

Authors:  Amy E Taylor; Alexandra N Carey; Ramesh Kudira; Celine S Lages; Tiffany Shi; Simon Lam; Rebekah Karns; Julia Simmons; Kumar Shanmukhappa; Maha Almanan; Claire A Chougnet; Alexander G Miethke
Journal:  Hepatology       Date:  2018-09-30       Impact factor: 17.425

5.  Posttranslational regulation of polycystin-2 protein expression as a novel mechanism of cholangiocyte reaction and repair from biliary damage.

Authors:  Carlo Spirli; Ambra Villani; Valeria Mariotti; Luca Fabris; Romina Fiorotto; Mario Strazzabosco
Journal:  Hepatology       Date:  2015-10-10       Impact factor: 17.425

6.  Microscopic examination of spatial transcriptome using Seq-Scope.

Authors:  Chun-Seok Cho; Jingyue Xi; Yichen Si; Sung-Rye Park; Jer-En Hsu; Myungjin Kim; Goo Jun; Hyun Min Kang; Jun Hee Lee
Journal:  Cell       Date:  2021-06-10       Impact factor: 66.850

7.  Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model.

Authors:  Tamara Potikha; Orit Pappo; Lina Mizrahi; Devorah Olam; Sebastián M Maller; Gabriel A Rabinovich; Eithan Galun; Daniel S Goldenberg
Journal:  FASEB J       Date:  2019-03-21       Impact factor: 5.834

8.  Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.

Authors:  Kelli A Lytle; Carmen P Wong; Donald B Jump
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

Review 9.  Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies.

Authors:  Stefania Cannito; Chiara Milani; Andrea Cappon; Maurizio Parola; Mario Strazzabosco; Massimiliano Cadamuro
Journal:  Int J Mol Sci       Date:  2018-12-04       Impact factor: 5.923

10.  Epigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent Hepatic Fibrosis.

Authors:  M L Arffa; M A Zapf; A N Kothari; V Chang; G N Gupta; X Ding; M M Al-Gayyar; W Syn; N M Elsherbiny; P C Kuo; Z Mi
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.